Navigation Links
Jazz Pharmaceuticals Announces Reduction in Force to Reflect Streamlined Operations
Date:12/16/2008

PALO ALTO, Calif., Dec. 16 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced a reduction in force of 71 employees, or approximately 24 percent of its work force, to lower operating expenses. The company expects to record a charge of approximately $1.9 million in the fourth quarter of 2008 related to this workforce reduction. Separately, Jazz Pharmaceuticals announced today that its Chief Financial Officer, Matt Fust, has decided to leave the company at year end to pursue other professional interests. His responsibilities will be assumed by other members of the executive management team.

The reduction does not affect the company's sales force. Jazz Pharmaceuticals currently markets and sells XYREM(R) (sodium oxybate) and LUVOX CR(R). The company will continue development of JZP-6 (sodium oxybate) for the treatment of fibromyalgia syndrome. In a recent press release, the company announced positive top-line results from the first of two pivotal Phase III clinical trials of JZP-6. JZP-8, Jazz Pharmaceuticals' product candidate providing intranasal delivery of clonazepam for the treatment of acute repetitive seizures, is continuing its Phase II clinical trial.

"Concentrating our company's efforts on growing sales of our commercial products and pursuing selected development programs, while streamlining our operations, will reduce ongoing operating expenses and minimize the need for additional financing," said Samuel Saks, M.D., Chief Executive Officer of Jazz Pharmaceuticals. "We thank all of our employees for their hard work on behalf of the company and their efforts to help us provide important products for patients and physicians. In particular, I would like to thank Matt for his many contributions since the formation of the company."

About Jazz Pharmaceuticals, Inc.
'/>"/>

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... Congruent Software agrees ...cluding project accounting clients) to Synergy Bus... Seattle, WA (PRWEB) December...oday it has acquired the Microsoft Dynamics SL pra...ss technology provider. The move was necessary due...
(Date:12/1/2009)..., , HARBIN, China, Dec. 1 /PRNew...c. ("China Sky One Medical" or "the Company") (Nas...tical company developing and producing,over-the-co...C"), today,announced that the Company has engaged ...rvice Company ("MDK") to serve as its exclusive sa...
(Date:12/1/2009)... A new clinical study prese...cine shows that three-dimensional (3-D) automated ... software during an in vitro fertilization (IVF) c...nal manual measurement of the follicles. , ...009 -- The Advanced Fertility Center of Chicago ha...
(Date:11/30/2009)..., , COLUMBUS, Ohio, Nov. 30 ...rt for one of the nation,s first minority business...ld in Cleveland December 3, is called "Transformin... Business Early-Stage Capital Summit." It will fea...l minority business leaders and local minority ent...
Breaking Biology Technology:Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 2Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 3China Sky One Medical, Inc. Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia 2China Sky One Medical, Inc. Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia 3Computerized IVF Follicle Measurements are Faster and Give High Success Rates, Says Research from Chicago Fertility Doctors Richard Sherbahn and Todd Deutch 2Computerized IVF Follicle Measurements are Faster and Give High Success Rates, Says Research from Chicago Fertility Doctors Richard Sherbahn and Todd Deutch 3Ohio Capital Fund Announces Sponsorship of Minority Business Conference 2
...d adage "a watched pot never boils" surely never t...anorods. , A new study from researchers at Rensse... invisible layer of the nanomaterials to the botto...ergy is required to bring water to boil. This incr...ing computer chips, improving heat transfer system...
...all/ - Dragon Pharmaceutical Inc.,("Dragon Pharma"...), a,leading international pharmaceutical company,...lders Meeting held on June 26, 2008 in Shenzhen,Ch...% of the outstanding shares,represented at this me...ight persons to serve as members of the Board of D...
.../ - Edmonton will be home to the,world,s first ind...nicipal,solid waste. The City has signed a 25-year...st ethanol producer and Enerkem, a leading biofuel...acility will initially produce 36 million,litres o...oxide (CO2),footprint by more than 6 million tonne...
Other Biology Technology:On the boil: New nano technique significantly boosts boiling efficiency 2On the boil: New nano technique significantly boosts boiling efficiency 3Edmonton to be site of world's first industrial scale municipal waste-to-ethanol facility 2Edmonton to be site of world's first industrial scale municipal waste-to-ethanol facility 3Edmonton to be site of world's first industrial scale municipal waste-to-ethanol facility 4Edmonton to be site of world's first industrial scale municipal waste-to-ethanol facility 5
(Date:11/30/2009)..., New Orleans, LA Researchers from LSU Health Sc... Eunice Kennedy Shriver National Institute of Chil...hool of Public Health, Brigham and Women,s Hospita...first time that drinking more than 5 servings of s...ears to significantly elevate the risk of developi...
(Date:11/30/2009)..., HOBOKEN, N.J. - The inaugural Global Conferenc...mber 3-4, 2009, in Washington, DC, focuses on the ...erprises of critical importance to society. ,...ty of research activity around targeted complex sy...This year,s topic includes Critical Infrastructure...
(Date:11/30/2009)..., Take advantage of lower early bird registration...teoporosis congress of 2010 at http://www.iofwco-...t congress of the International Osteoporosis Found...and Economic Aspects of Osteoporosis and Osteoarth...round the world are expected to attend. The exciti...
Breaking Biology News(10 mins):Sugary cola drinks linked for first time to higher risk of gestational diabetes 2Sugary cola drinks linked for first time to higher risk of gestational diabetes 3First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4 2Employers of Any Size Can Now Benefit From Dependent Eligibility Audits Thanks to New Audit Toolkit 60131 1Employers of Any Size Can Now Benefit From Dependent Eligibility Audits Thanks to New Audit Toolkit 60131 2Syngenta Ventures Invests in U S Biotech Company Metabolon 14601 1Syngenta Ventures Invests in U S Biotech Company Metabolon 14601 2Syngenta Ventures Invests in U S Biotech Company Metabolon 14601 3UT Southwestern patient first in North Texas to receive newest generation heart failure device 10532 1UT Southwestern patient first in North Texas to receive newest generation heart failure device 10532 2UT Southwestern patient first in North Texas to receive newest generation heart failure device 10532 3
...hrough a tropical or temperate forest immediately ...uctures of the plant world, but our knowledge of h...ll incomplete. Now, with data emerging from many ...to unravel the details of plant architecture at th...s for crop yield improvement, biofuel production, ...
...Geological Survey is partnering with the Chilean g...mergency response system for the country after the... Following the eruption, the USGS helped Chile to ...data in real time and help warn the public of furt...r of intent with President Bachelet of Chile to he...
..., Mass., USA (June 25, 2008) Cell is ranked cel... data released in the 2007 Journal Citation Report...eleased this month, Cell ,s impact factor increas... higher than competing research journals Science ...l is the flagship journal of Cell Press, an impri...
Other Biology News:How to build a plant 2How to build a plant 3USGS to help Chile develop volcano early warning system 2
Bromophenol Blue from USB Corp.
...Oligo Microarray, 22K enables researchers to simul...ociated with biological functions, growth processe...croarray contains sequences representing estimated...uses on well annotated genes selected by Dr. Shosh...
...ax DW4 liquid handling system from Molecular Devic...g all in one instrument. The system handles a vari...ing96-, 384- and 1536-welland is the first to hand...een optimized to dispense from four different chan...
...escence Test Plate consists of an anodized aluminu...Fluorescent Compounds embedded in polymerized matr...d Synergy Multi-Detection Readers. This multi-func...e reducing the need for tedious wet testing. Works...
Biology Products: